Evaluation of the Level of Zinc and Malondialdehyde in Basal Cell Carcinoma
- PMID: 28894712
- PMCID: PMC5575390
Evaluation of the Level of Zinc and Malondialdehyde in Basal Cell Carcinoma
Abstract
Background: Basal Cell Carcinoma (BCC) is one of the most common skin cancers in the world and that use to lifestyle, increasing chemical pollutions, environmental factors and poor nutrition. The most important cause of this cancer is oxidative stress and free radicals so antioxidant activities for the body are so important. The aim of this study was to determine the variation of zinc and (Malondialdehyde) MDA in BCC patients.
Methods: This study has been performed on case and control patients from 2013 to 2014. The samples were collected from cell carcinoma patients at Razi Hospital in Tehran, Iran. We evaluated the level of zinc with the use of Atomic Absorption Spectroscopy (AAS) method. Besides, we evaluated MDA with colorimetric assay.
Results: The concentration of MDA was significantly higher in case group in comparison to control group (P=0.001). In addition, case group had lower concentration of zinc than the control group (P=0.000). There was no correlation between MDA and body mass index (BMI) and between zinc and BMI.
Conclusion: All the patients with BCC showed a significant MDA serum in comparison with control group. However, significant decrease in zinc serum of the patients was seen that is because of consuming zinc during oxidative stress process so topical use of zinc in the form of 2+ ions could be effective on antioxidant protection against the sun UV radiation.
Keywords: Basal cell carcinoma; Malondialdehyde; Skin cancer; Zinc.
Conflict of interest statement
Conflict of Interests The authors declare that there is no conflict of interest.
Similar articles
-
Elemental Zinc Is Inversely Associated with C-Reactive Protein and Oxidative Stress in Chronic Liver Disease.Biol Trace Elem Res. 2017 Aug;178(2):189-193. doi: 10.1007/s12011-016-0919-5. Epub 2017 Jan 5. Biol Trace Elem Res. 2017. PMID: 28058664 Clinical Trial.
-
Effect of zinc supplementation on antioxidant activity in young wrestlers.Biol Trace Elem Res. 2010 Apr;134(1):55-63. doi: 10.1007/s12011-009-8457-z. Epub 2009 Jul 14. Biol Trace Elem Res. 2010. PMID: 19597720 Clinical Trial.
-
Effects of zinc supplementation on antioxidant status and lipid peroxidation in hemodialysis patients.J Ren Nutr. 2013 May;23(3):180-4. doi: 10.1053/j.jrn.2012.08.012. Epub 2012 Nov 7. J Ren Nutr. 2013. PMID: 23140661 Clinical Trial.
-
Evaluation of the Randox colorimetric serum copper and zinc assays against atomic absorption spectroscopy.Ann Clin Biochem. 2009 Jul;46(Pt 4):322-6. doi: 10.1258/acb.2009.008253. Epub 2009 Jun 1. Ann Clin Biochem. 2009. PMID: 19487410
-
Variations in clinical presentation of basal cell carcinoma.Acta Clin Croat. 2008 Mar;47(1):25-30. Acta Clin Croat. 2008. PMID: 18714644 Review.
Cited by
-
The Role of Chosen Essential Elements (Zn, Cu, Se, Fe, Mn) in Food for Special Medical Purposes (FSMPs) Dedicated to Oncology Patients-Critical Review: State-of-the-Art.Nutrients. 2023 Feb 17;15(4):1012. doi: 10.3390/nu15041012. Nutrients. 2023. PMID: 36839370 Free PMC article. Review.
-
Trace element zinc and skin disorders.Front Med (Lausanne). 2023 Jan 17;9:1093868. doi: 10.3389/fmed.2022.1093868. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36733937 Free PMC article. Review.
-
Regression of bovine cutaneous papillomas via ivermectin-induced immunostimulant and oxidative stress.J Adv Vet Anim Res. 2021 Jul 20;8(3):370-377. doi: 10.5455/javar.2021.h525. eCollection 2021 Sep. J Adv Vet Anim Res. 2021. PMID: 34722735 Free PMC article.
-
Non-Melanoma Skin Cancer: Assessing the Systemic Burden of the Disease.Cancers (Basel). 2025 Feb 19;17(4):703. doi: 10.3390/cancers17040703. Cancers (Basel). 2025. PMID: 40002296 Free PMC article. Review.
-
Evaluation of Haptoglobin Genotype and Some Risk Factors of Cancer in Patients with Early Stage Esophageal Cancer.Asian Pac J Cancer Prev. 2019 Oct 1;20(10):2897-2901. doi: 10.31557/APJCP.2019.20.10.2897. Asian Pac J Cancer Prev. 2019. PMID: 31653132 Free PMC article.
References
-
- McCusker M, Basset-Seguin N, Dummer R, et al. (2014). Metastatic basal cell carcinoma: prognosis dependent on anatomic site and spread of disease. Eur J Cancer, 50(4): 774–83. - PubMed
-
- Gorlin RJ. (2004). Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med, 6: 530–9. - PubMed
-
- Lo Muzio L, Nocini PF, Savoia A, et al. (1999). Nevoid basal cell carcinoma syndrome. Clinical findings in 37 Italian affected individuals. Clin Genet, 55(1): 34–40. - PubMed
LinkOut - more resources
Full Text Sources